HIV-1 infection remains a significant global health challenge, primarily due to its ability to establish a latent reservoir within the host's immune cells, particularly CD4 + T cells. This ...
HIV-infected cells respond to viral invasion with various ... pathway thus bypassing cortical actin. Strebel K, Klimkait T, Martin MA . A novel gene of HIV-1, vpu, and its 16-kilodalton product.
we haven't got a solution to the problem yet," he said. An HIV infection is so difficult to cure because the virus is incredibly effective at hiding in our cells. When HIV infects our bodies ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
Overall, the study provides not only a detailed map of the translational landscape of HIV-1 infected cells but also a wealth of potential targets for therapeutic intervention. The identification ...